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ComplicationAbstract Objective: To determine incidence and risk factors of adverse events associated with
pediatric cardiac catheterization in the initial experience of our institution.
Patients and methods: The retrospective cohort study was conducted on 262 children with congen-
ital heart disease who received cardiac catheterization in our catheterization between April 2010 and
April 2013. Diagnostic CC was performed in 176 patients and therapeutic CC in 86 patients. All
children’s electronic and paper chart records were reviewed to obtain demographic, procedural,
and treatment data. The severities of AE were further classiﬁed into minor, moderate and higher
severity AE including levels 3, 4 or 5 AE.
Results: Of 262 patients (147 females, 55.4%), AE occurred in 31 studies (11.8%), in children rang-
ing in age from 3 days to 16 years. There were 7 patients with higher severity AE (2.7%), 7 patients
with moderate AE (2.7%) and 17 patients (6.5%) with minor AE. Vascular complications repre-
sented the majority (n= 12; 38.7%). Two children died within 24 h (0.7% of total case numbers).
The risk factors for a complication included patient low body weight and the second year of our
institution experience.
Conclusions: Pediatric cardiac catheterization by well trained team of pediatric cardiologists in a
new center is effective. The rate of occurrence of AEs approximated to those which are reported
by various interventional pediatric cardiology centers around the world. The lower body weight
and the second year of initial experience are risk factors for occurrence of AE.
ª 2015 The Author. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Cardiac catheterization has revolutionized the management of
pediatric cardiac disease. Pediatric cardiac catheterization lab-
oratories are now increasingly being used for therapeuticprocedures. Also, diagnostic catheterizations still play an
important role in hemodynamic study. Both therapeutic
and diagnostic procedures are associated with some risks
because of their invasive nature.1–3 Cardiac catheterization
associated complications including arrhythmia, massive bleed-
ing, heart perforation, cardiac tamponade, thromboembolism,
shock, hypoxemia and vessel occlusion remain a major con-
cern for performing the procedure.4–7 A large multicenter
experience with life-threatening events in congenital cardiac
46 S.H. Alicatheterization was reported a low incidence of life-threatening
events (2.1%) and mortality (0.28%) despite the complexity of
modern patients and procedures.8 This ﬁnding is well docu-
mented in Vitiello et al’s series of 4500 pediatric CCs in
10 years (2.1% major complications, 9.3% minor complica-
tions and 0.14% CC-related mortality).2 Our study aimed to
evaluate the incidence of adverse events and risk of pediatric
cardiac catheterization in our center in its initial experience.
2. Methods and patients
The study was conducted on 262 children who received cardiac
catheterization in our tertiary care hospital between the period
of April 2010 and April 2013. All CCs were performed by pedi-
atric cardiologists. Informed consents were obtained from the
parents of children after complete explanation to all possible
minor or major adverse events of the procedure. Their medical
records, CC reports, medications and interventions on the
catheterization system were reviewed retrospectively by one
pediatric cardiologist.
Children were prepared and anesthetized according to the
deﬁnite protocol. Critically ill children, those with circulatory
insufﬁciency symptoms scheduled for examinations on an
urgent or emergency basis, as well as neonates and infants
below 6 months of age were not premedicated. Children above
6 months of age received midazolam 30 min before the proce-
dure. General anesthesia with endotracheal intubation was
applied in neonates and infants below one year of age, patients
qualiﬁed for cardiac interventional procedures necessitating
using transesophageal examination, and those with the symp-
toms of circulatory failure scheduled for urgent and emergency
examinations. Deep sedation was applied in pulmonary valvu-
loplasty and transcatheter PDA closure in children more than
6 months.
Non-invasive monitoring (pulsoxymetry, indirect blood
pressure measurements, ECG, body temperature) was initiated
before the induction of anesthesia. In children with severe cir-
culatory insufﬁciency requiring vascular agents, arterial pres-
sure was measured invasively.
After the diagnostic or interventional procedure, patients
were sent to the postoperative care unit or recovery room
and observed for several hours. Those conscious, with efﬁcient
respiration and stable circulation (appropriately to the heart
defect and pre-procedure status) were transferred to the car-
diac intensive surveillance unit.
Invasive procedures were carried out by the team of well
trained interventional pediatric cardiologists from well estab-
lished experienced centers and from our institution.
Examinations were carried by a double-plane angiograph
imaging. Fluoroscopic time of each examination was recorded
automatically by the CC system.
2.1. Deﬁnition of AEs
AEs were deﬁned as any anticipated or unanticipated event
from which injury could have occurred or did occur, poten-
tially or deﬁnitely because of performing the catheterization.
Events were recorded at the time of identiﬁcation, either at
the time of the case or later if determined to be related to
the procedure. We used previously established and tested def-
initions for AE severity ranging from levels 1–5. For thisanalysis, clinically important higher severity AE was deﬁned
as levels 4, or 5 AE. So adverse events were deﬁned as (1)
adverse events related to the catheterization procedure, (2)
identiﬁed during or after the procedure resulting in a change
in patient condition, (3) life-threatening if not treated, (4)
requiring major intervention, such as invasive monitoring or
major transcatheter bailout procedure (severity level 4), and
(5) resulting in death and emergency surgery or failure to wean
from extracorporeal membrane oxygenation (severity level
5).9,10
Statistical analyses were done using intercooled STATA
program version 9.2. Data were presented as mean and stan-
dard deviation for quantitative data or as number and percent
if data were qualitative. Logistic regression analysis was used
to calculate both odds ratio and P values. P values less than
0.05 were consider signiﬁcant.3. Results
A total of 262 children with CHD received cardiac catheteriza-
tion in our tertiary care hospital between the period of April
2010 and April 2013. Among those patients, 86 patients
received diagnostic CC and 176 patients received therapeutic
CC consisted of six different procedures as in Fig. 1:
(1) 12 (6.8%) patients had coil embolizations for patent
ductus arteriosus with COOK detachable and PFM coils, (2)
32 (18.1%) patients received septal occluder procedures for
atrial septal defect, (3) 63 (35.8%) patients received balloon
valvuloplasty procedures for valvular pulmonary stenosis or
aortic stenosis, (4) 7 (3.9%) patients who had transposition
of the great arteries received balloon atrioseptostomy proce-
dures, (5) 58 (32.9%) patients had received PDA closure by
Amplatzer Duct Occluder and (6) 4 (2.3%) patients had
received VSD closure by different types of Amplatzer muscular
VSD and Duct occluders.
AEs occurred in 31 of the total 262 patients (11.8%),
including 9 out of 86 diagnostic CC (10.4%) and 22 out of
176 therapeutic CC (12.5%). The AEs were classiﬁed into three
categories minor, moderate and higher severity according to
the severities level of previously established deﬁnition of AE.
Higher severity (level 4 or 5) AE occurred in 7 patients
(2.7%) of cases among the total 262 CC procedures.
Moderate complications occurred in 7 patients (2.7%).
Minor complications occurred in 17 patients (6.5%) of cases.
All different kinds of AE were categorized into four groups
as shown in Table 1. Group 1––arrhythmias: 6 patients
(19.3%) with symptoms including transient bradycardia, 1st
to 3rd degree of atrioventricular block, paroxysmal supraven-
tricular tachycardia and ventricular tachycardia. Group 2––hy-
poxia: 4 patients (12.9%) with symptoms ranging from
transient oxygen desaturation to remarkable apnea and brady-
cardia requiring cardiopulmonary resuscitation and even
endotracheal intubation.
Group 3–– femoral vessel injury: 12 patients (38.7%) who
suffered temporary loss of femoral artery pulsation, one
patient who suffered signiﬁcant bleeding at the puncture sites
and required blood transfusion and 3 patients who suffered
from femoral artery thrombosis requiring systemic hepariniza-
tion. Group 4––miscellaneous: Six patients (19.4%) with symp-
toms including Embolization of devices, cardiac tamponade
and rupture of balloon during pulmonary valvuloplasty.
Figure 1 Types of interventional procedures.
Table 1 Types of diagnostic and interventional procedures.
Procedure n (%)
Diagnostic 86 (32.8%)
Interventional 176 (67.2%)
Balloon atrioseptostomy 7 (3.9%)
Pulmonary valvuloplasty 60 (34.1%)
Balloon dilation of coarctation of aorta 3 (1.7%)
PDA closure by Amplatzer duct occluder 58 (32.9%)
PDA closure by coils 12 (6.8%)
ASD closure by Amplatzer septal occluder 32 (18.1%)
VSD closure by diﬀerent Amplatzer occluder 4 (2.3%)
Table 2 Technique-related complications.
Procedure Cause of complication Complication N
Pulmonary
valvuloplasty
During angiography Pericardial eﬀusion 1
From anesthesia Severe hypoxia and
apnea
1
Manual inﬂation of
balloon
Rupture of balloon 2
During catheter
manipulation
Supraventricular
tachycardia
3
Perforation of RVOT
with Terumo guide wire
Hemopericardium 1
ASD closure
by
Amplatzer
device
Severe bleeding from
femoral vein requiring
blood transfusion
No adequate
compression after
removal of sheath
1
During catheter
manipulation
Supraventricular
tachycardia
2
After device
deployment
Atrial ﬂutter 1
Perforation of RVOT
by guide wire
Cardiac
tamponade by
hemopericardium
1
PDA closure Undersizing of
pulmonary end
Embolization into
left pulmonary
artery
1
From anesthesia Sinus arrest 1
From femoral artery
cannulation
Loss of femoral
pulse
6
Diagnostic From nature of Fallot
tetralogy
Severe cyanotic
spell
1
Sinus arrest in Fallot
tetralogy
Severe cyanotic
spell progress to
death
1
From femoral artery
cannulation
Loss of femoral
pulse
6
VSD closure Undersizing of VSD
diameter
Embolization of
device into right
pulmonary artery
1
From catheter
manipulation near
bundle of Hiss
Ventricular
tachycardia
1
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The mean age and body weight of the 31 AE-suffering patients
and 231 non-AE patients are presented in Table 2, respectively.
Furthermore, those suffering AE showed signiﬁcantly different
mean body weight from the rest of the patients (Table 2), while
the different mean age approached to signiﬁcance in compar-
ing non-AE patients and AE-suffering patients.
AE patients required a signiﬁcant longer procedure time
than non-AE patients (81.2 ± 34.7 vs. 47.8 ± 10.3 min,
p< 0.04, Table 3). Fluoroscopic time was slightly longer in
the AE group as compared to the non-AE group
(28.37 ± 19.58 vs 18.65 ± 10.31 min, p= 0.08, Table 3).
When occurrence of AE was compared between diagnostic
and therapeutic catheterization, the therapeutic catheterization
was found to have a higher incidence of AE (70.96%) than the
diagnostic catheterization but was not signiﬁcant (p= 0.46,
Table 2).
Through four years of experience of pediatric catheteriza-
tion in our institution, the AE occurrence was signiﬁcantly
higher in the year 2011 than those in other years which was
the year that device closure of ASD, PDA and VSD was
started (p= 0.01, odds ratio 4.03, Table 2 and Fig. 2).
3.2. The selected cases who suffered from higher severity AEs
The ﬁrst case was a 10-day-old, 2.5 kg male newborn with sev-
ere pulmonary valvular stenosis whose right ventricle outﬂow
tract was accidentally perforated by a 4 French multipurpose
catheter. Cardiac tamponade then occurred and was managed
emergently with needle pericardiocentesis. The bleeding
stopped spontaneously. The newborn received a right ventric-
ular outﬂow tract reconstruction after one week.
The second case was a 10 month, 8 kg female with severe
pulmonary valvular stenosis whose right ventricle outﬂow tractwas accidentally perforated during angiography. Moderate
amount of pericardial effusion resolved spontaneously within
three days. The procedure was repeated after one month with
successful pulmonary valvuloplasty.
The third case was a 6 years, 15 kg male with ASD secun-
dum with preserved rim, which was closed by 12 mm
Amplatzer occluder and the procedure passed smoothly. On
Table 3 Risk factors associated with complication.
No Complication Complication P OR CI
N= 231 31
Age (month) 37.80 ± 37.07 26.22 ± 34.24 0.09 0.98 0.97–1.00
Weight 13.60 ± 8.75 10.50 ± 6.68 0.047 0.93 0.86–0.99
Procedure time 47.8 ± 10.3 81.2 ± 34.7 0.03 1 0.98–1.00
Fluoroscopy time 18.65 ± 10.31 28.37 ± 19.58 0.34 1 0.99–1.02
Intervention type
Diagnostic 77 (33.33%) 9 (29.03%)
Therapeutic 154 (66.67%) 22 (70.96%) 0.46 1.39 0.62–3.12
Intervention date
2013 55 (23.81%) 4 (12.90%) 0.65 0.83 0.17–3.9
2012 73 (31.60%) 4 (12.90%) 0.69 0.75 0.13–4.24
2011 58 (25.11%) 17 (54.84%) 0.01 4.03 1.20–17.33
2010 45 (19.48%) 6 (19.35%) 0.36 1.83 0.40–9.34
OR= odds ratio; CI = conﬁdence interval.
Figure 2 Rate of adverse events per year of interventions.
48 S.H. Alithe next day, Cardiac tamponade of hemopericardium
occurred and was managed emergently with needle pericardio-
centesis without further accumulation.
The fourth case was a 9 month, 7 kg female child who expe-
rienced complication during the procedure with Amplatzer
duct occluder embolization to the left pulmonary artery. The
PDA was closed with ADO size 8/6 mm without residual shunt
in second aortogram. During release of device, embolization
occurred spontaneously. We thought embolization occurred
secondary to increased ﬂow through the patent ductus arterio-
sus with possible under-sizing of the device. Patient was
referred to surgery for device removal and closure of PDA.
No catheter retrieval was attempt as in Fig. 3.
The ﬁfth case was a 8-month-old, 7 kg infant with moderate
sized PDA which was closed by Amplatzer duct occluder 6/4under general anesthesia. The procedure passed smoothly
but during recovery from anesthesia unexpectedly sinus
bradycardia and apnea occurred. Endotracheal intubation
and resuscitation were instituted but unfortunately, the infant
died. We thought the complication occurred from anesthetic
drugs.
The sixth case was a 8 years, 16 kg female child who expe-
rienced complication during the procedure with Amplatzer
duct occluder embolization to the right pulmonary artery.
The VSD PM was closed with ADO size 8/6 mm. During
release of device, embolization occurred spontaneously. We
thought embolization occurred due to under-sizing of the
device. Patient was referred to surgery for device removal
and closure of VSD PM after repeated attempts of catheter
retrieval as in Fig. 4.
Figure 3 ADO embolization to the left pulmonary artery during
its release after PDA closure.
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Pediatric cardiac catheterization has shifted from a diagnostic
tool to a therapeutic one. Several studies have demonstrated
that the rate of complications is higher in therapeutic proce-
dures than that in diagnostic procedures.2,11,12
This is in agreement with the results of our present study.
The occurrence of AEs during the therapeutic catheterization
was found to have a higher incidence of AEs (70.96%) but this
was not statically signiﬁcant.Figure 4 ADO embolization to the right pulmonary artery
during VSD PM closure and an attempt of its retrieval.The 4-year study of pediatric CC in our center, found that
the incidence of all AEs was 11.8%, including 2.7% of higher
severity AE. Two patients died within 24 h of catheterization
which represented 0.7% of total case numbers and two deaths
were infant <1 year. The two deaths were directly attributed
to anesthesia in one patient and to the nature of hypercyanotic
spell of Tetralogy of Fallot in another patient. This was similar
to most studies in which the mortality was signiﬁcantly higher
in children <1 year of age and particularly in neonates.2,13
The results in this series are consistent with the previous
studies which had reported overall complication rates of 7.8–
24% and mortality rates ranging from 0.14% to 2.7%.1,5,14
Furthermore, major complications had been reported to vary
from 1.4% to 11% and minor complications from 6% to
11.7%.1,5,14,15
From a large review of Japanese Pediatric Interventional
Cardiology procedures conducted between 2004 and 200815
the authors reported that deaths occurred in 0.13% and major
complications in 3.7% of 8446 therapeutic procedures,
although the complications of the diagnostic procedures were
not included.
In another study of a large multicenter experience with life-
threatening events in congenital cardiac catheterization, the
authors reported a low incidence of life-threatening events
(2.1%) and mortality (0.28%) despite the complexity of dis-
eases and procedures. The predictors of life-threatening events
were age < 1 year, increased hemodynamic vulnerability, and
high procedure complexity.8
Low body weight and year of intervention were major risk
factors for AE occurrence in our series (Table 3). This is con-
sistent with the previous studies which had reported that the
major risk factors were young age, low body weight and
patients who had therapeutic catheterization.18,8
Vascular complications were the most common events in
the Toronto reports and ultrasound studies had reported ilio-
femoral thrombus in up 10% of children 24 h after catheteriza-
tion.16 Arterial thrombosis requiring treatment by systemic
heparin or thrombolytics, had been reported to be 4% of car-
diac catheter procedures complication. Transient pulse loss not
requiring treatment was probably more commoner.1
This is in agreement with our study in which vascular com-
plication represented 38.7% of all complications. This was
reﬂected on our experience by choosing the smallest sheath
for age which could be used in femoral artery and repeated
examination of distal pulse in early hours after procedure for
early detection of femoral artery thrombosis and treatment.
Arrhythmias occurred rather frequently in our series, which
is consistent with other reports. Most of the arrhythmias were
transient and only two cases required pharmacological treat-
ment in this study. Most arrhythmias were associated with
inadvertently probing or compressing on the myocardium or
conduction tissue, so it is safer to use as much soft catheters
as possible rather than the stiff-end catheters, judicious cathe-
ter manipulation and correction of metabolic abnormalities
are crucial to preventing serious arrhythmias.17,18
Gained from our experience, soft-end catheters being used
in our center are accompanied by gentle catheter manipulation
to reduce the incidence of arrhythmias and perforation.
Misplacement of a device during therapeutic embolization
is a recognized complication that can be satisfactorily dealt
with by transcatheter retrieval without rescue surgery. For
retrieval to be successful it is important to have a wide
50 S.H. Aliselection of retrieval equipments and to be conversant with
their use.19 This was contrast to our study, in which emboliza-
tion occurred in two patients. In one patient in whom
embolization occurred during deployment of ADOI to close
perimembranous VSD, many attempts for retrieval were done
by snare catheter without success. Patient was referred for sur-
gical removal of embolized device and closure of VSD.
Cardiac perforation with cardiac tamponade is the worst
situation for all interventional cardiologists. This complication
is always the ﬁrst one to be ruled out whenever hypotension
suddenly occurs during CC. The diagnosis can be conﬁrmed
by either ﬂuoroscopy or echocardiography. In addition, an
emergent needle pericardiocentesis to drain off bloody pericar-
dial ﬂuid should be performed by the operating cardiologist
without delay, as well as cardiopulmonary resuscitation. In
the case of a large volume of bleeding, the cardiac surgeon
needs to create a pericardial window.18 This occurred in two
cases of our study which necessitated an emergent needle peri-
cardiocentesis to drain off bloody pericardial ﬂuid and was
performed by our operating cardiologist.
Statistical analysis of our results showed a signiﬁcant posi-
tive relationship between experience and complications. The
effect of the learning curve was responsible for the improve-
ment in the procedure outcome. Experience gained throughout
the four-year study period was reﬂected on better case selec-
tion, accurate sizing of the defect diameter, better choice of
closure device type and size, adopting different techniques in
dealing with device closure, conﬁrming the position of the
device before releasing and deployment, balloon dilation of
valve with recommended ratio in literatures and the smallest
sheath used for vessels, and also experience gained was
reﬂected on anesthesiologists in dealing with small children.
This is highly indicative of the importance of experience and
the rising learning curve in reducing the adverse events.
This was stated by the father of cardiac catheterization,
Charles Mullins, the complications related to all cardiac
catheterization procedures are more frequent during the
‘‘learning phases’’ of the procedures. The ‘‘learning curve’’ also
pertains to the development and use of new products and pro-
cedures by the experienced catheterizing physicians and/or in
laboratories.115. Study limitations
Some limitations exist in the present study. These include the
relatively small number of patients and retrospective nature
of a study. More studies with a large number of patients are
needed to be more representative of the diverse adverse events.
The relation of adverse events to the operator was not
analyzed.6. Conclusion
Pediatric cardiac catheterization by well trained team of pedi-
atric cardiologists in a new center is effective. The lower body
weight and the second year of initial experience are risk factors
for occurrence of AE. The importance of experience and the
rising learning curve were reﬂected by signiﬁcant reduction in
the incidence of adverse events after second year.Conﬂict of interest
The author declare that there are no conﬂicts of interest.
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